Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
14.91
+0.53 (3.69%)
At close: Mar 9, 2026, 4:00 PM EDT
14.92
+0.01 (0.07%)
After-hours: Mar 9, 2026, 4:45 PM EDT
Eikon Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -309.52 | -243.81 | -242 |
| Depreciation & Amortization | 25.29 | 25.39 | 17.75 |
| Asset Writedown & Restructuring Costs | 21.02 | - | 35 |
| Loss (Gain) From Sale of Investments | -6.11 | -9.46 | -21.11 |
| Stock-Based Compensation | 17.35 | 12.43 | 9.54 |
| Change in Accounts Payable | -0.11 | 2.95 | 0.24 |
| Change in Other Net Operating Assets | 81.55 | 77.7 | 9.74 |
| Operating Cash Flow | -170.53 | -134.8 | -190.85 |
| Capital Expenditures | -86.19 | -84.8 | -28.51 |
| Investment in Securities | -127.71 | 236.15 | 165.46 |
| Investing Cash Flow | -213.9 | 151.35 | 136.95 |
| Issuance of Common Stock | 0.91 | 0.24 | 0.4 |
| Financing Cash Flow | 351.06 | 0.24 | 105.81 |
| Net Cash Flow | -33.37 | 16.8 | 51.91 |
| Free Cash Flow | -256.73 | -219.6 | -219.36 |
| Free Cash Flow Per Share | -91.50 | -87.16 | -108.26 |
| Cash Interest Paid | 0.89 | 0.03 | 0.04 |
| Levered Free Cash Flow | - | -190.73 | - |
| Unlevered Free Cash Flow | - | -190.71 | - |
| Change in Working Capital | 81.44 | 80.65 | 9.98 |
Source: S&P Capital IQ. Standard template.
Financial Sources.